Search
TELA Bio Inc
TELAAdd to Watchlist
0.706USD
-0.034-4.65%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
27.91MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-4.65%
5 Days
-11.91%
1 Month
-21.63%
6 Months
-38.11%
Year to Date
-40.20%
1 Year
-64.18%
Key Figures
0.720Open
0.778High
272.28KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.69%Turnover Ratio
0.740Prev. Close
0.670Low
130.11KTurnover
LossP/E Static
1.54P/B
0.00%Div Yield TTM
-54.15%ROA
2.20052wk High
1.68Volume Ratio
-37.84MNet Profit
39.55MShares
-0.7926EPS TTM
1.30Beta
-616.62%ROE
0.50152wk Low
14.54%Amplitude
65.69%Gross Margin
27.91MMarket Cap
-4.23Reward/Risk
5.60%Risk Rate
TradingKey Stock Score of TELA Bio Inc
Currency: USD Updated: 2026-06-26Key Insights
TELA Bio Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 100 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.25.In the medium term, the stock price is expected to trend up.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
TELA Bio Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
TELA Bio Inc Highlights
StrengthsRisks
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 37.33% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 80.28M.
Overvalued
The company’s latest PE is -0.89, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 32.85M shares, decreasing 15.76% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.45.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
2.250
Target Price
+218.88%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
TELA Bio Inc News
US-Iran Ceasefire Hits Oil Prices Over 10% as US Stock Futures Surge Pre-Market
Easing tensions in the Middle East triggered a plunge of over 10% in crude oil prices, while the three major U.S. stock index futures and star tech stocks rallied broadly.
TradingKeyWed, Apr 8
Unveiling U.S. Stock “Money Printing Machines” — Insights Into the Business Essence of Star Stocks From Net Profit Margins
Using net profit margin as the core metric, this article provides an in-depth analysis of the business fundamentals of star stocks such as NVIDIA, Tesla, Apple, and Visa. Against the backdrop of a neutral-to-tight monetary environment, it reveals the profitability reality behind the S&P 500’s 13.2% benchmark and accurately identifies U.S. "money-printing machines" possessing significant pricing power.
TradingKeyThu, Apr 2
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
TELA Bio Inc Info
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
Ticker SymbolTELA
CompanyTELA Bio Inc
CEOKoblish (Antony)
Websitehttps://www.telabio.com/
Related Instruments
+2.87%
+1.47%
+0.64%
+1.14%
+1.52%
-0.32%
+5.22%
+1.47%
+1.16%
+2.06%
+0.18%
-0.14%
-0.27%
+1.18%
+2.33%
+3.03%
-0.62%
+0.32%
-0.71%
+0.45%Popular Instruments
51958.900
+206.700 (+0.40%)
29232.300
+244.800 (+0.84%)
7376.400
+44.400 (+0.61%)
15265.000
-17.000 (-0.11%)
68972.000
-536.000 (-0.77%)
6233.600
+26.500 (+0.43%)
69.805
-0.343 (-0.49%)
283.780
+8.630 (+3.14%)
192.530
-3.210 (-1.64%)
4067.030
-20.730 (-0.51%)
FAQs
What is the current price of TELA Bio Inc (TELA)?
The current price of TELA Bio Inc (TELA) is 0.71.
What is the symbol of TELA Bio Inc?
The ticker symbol of TELA Bio Inc is TELA.
What is the 52-week high of TELA Bio Inc?
The 52-week high of TELA Bio Inc is 2.20.
What is the 52-week low of TELA Bio Inc?
The 52-week low of TELA Bio Inc is 0.50.
What is the market capitalization of TELA Bio Inc?
The market capitalization of TELA Bio Inc is 27.91M.
Is TELA Bio Inc (TELA) currently rated as Buy, Hold, or Sell?
According to analysts, TELA Bio Inc (TELA) has an overall rating of Buy, with a price target of 2.25.
What is the Earnings Per Share (EPS TTM) of TELA Bio Inc (TELA)?
The Earnings Per Share (EPS TTM) of TELA Bio Inc (TELA) is -0.83.
